US Broker Ratings

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring an 80% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector, specifically in the medical devices industry, has caught the eye of investors with its significant potential upside...

Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating a Complex Landscape with a Tempting Forward P/E of 1.74

Bausch Health Companies Inc. (NYSE: BHC), headquartered in Laval, Canada, is a multifaceted player in the healthcare sector, primarily focusing on specialty and generic drug manufacturing. With a market capitalization..

Select Medical Holdings Corp (SEM) Stock Analysis: Capturing a Potential Upside of 37%

Select Medical Holdings Corporation (NYSE: SEM), a key player in the healthcare sector, is renowned for its expansive network of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: A 104% Upside Potential in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector with an impressive potential upside of 104.08%, as per analysts’ consensus. With a current market capitalization of $1.56 billion,..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 67% Potential Upside Amidst Market Challenges

As Novavax, Inc. (NASDAQ: NVAX) navigates the volatile waters of the biotechnology sector, individual investors are eyeing a compelling 67% potential upside. This Gaithersburg, Maryland-based company has carved out a..

Ocular Therapeutix, Inc. (OCUL): Investor Outlook Reveals 42.95% Potential Upside in Biotech Innovator

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a pioneering biopharmaceutical entity within the healthcare sector, offers a compelling case for investors with its innovative approach to treating ocular diseases. Headquartered in Bedford,..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth in a Challenging Healthcare Landscape

Pediatrix Medical Group, Inc. (NYSE: MD) is a significant player in the healthcare sector, specializing in newborn and maternal-fetal care services across the United States. With a market capitalization of..

Teladoc Health (TDOC) Stock Analysis: Navigating Virtual Healthcare’s Future with an 18% Upside Potential

Teladoc Health, Inc. (NYSE: TDOC) is a prominent player in the rapidly evolving virtual healthcare domain, offering a diverse array of services that span general medical consultations, mental health services,..

Enovis Corporation (ENOV) Stock Analysis: Unpacking the 68.93% Potential Upside

Enovis Corporation (NYSE: ENOV), a key player in the healthcare sector, particularly within the medical devices industry, presents a compelling investment opportunity with a significant potential upside. With a market..

Vera Therapeutics, Inc. (VERA): Investor Outlook on a Biotech with 194% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is drawing considerable attention in the healthcare sector as a promising player in the biotechnology industry. With a market capitalization of $1.38 billion, Vera is..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech With 32.47% Potential Upside

Liquidia Corporation (NASDAQ: LQDA) stands out in the biotechnology sector with its innovative approach to unmet patient needs, particularly in the field of pulmonary hypertension. Based in Morrisville, North Carolina,..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 25.52% Upside Potential Beckons Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is capturing investor attention with a promising potential upside of 25.52%. This global biopharmaceutical entity, known for its innovation..

Alvotech (ALVO) Stock Analysis: A Potential 116.85% Upside in the Healthcare Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based biopharmaceutical company, is gaining significant attention from investors seeking opportunities within the healthcare sector, particularly in the niche market of biosimilar medicines. With a market..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Evaluating the 37.59% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands at the intersection of biotechnology and cutting-edge technology, presenting both challenges and opportunities for investors. With a market capitalization of $2.05 billion, this clinical-stage..

Amicus Therapeutics, Inc. (FOLD) Investor Outlook: Exploring a 112% Potential Upside with Analyst Confidence

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a notable player in the biotechnology sector, presents a compelling case for investors with a striking potential upside of 112% based on current analyst ratings...

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a Potential 123% Upside in Biotech

In the high-stakes arena of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) is capturing the attention of investors with a compelling narrative and potential upside of 123.34%. With a focus on..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 162% Potential Upside in the Healthcare Sector

Dyne Therapeutics, Inc. (NASDAQ: DYN), a burgeoning player in the biotechnology industry, has been capturing the attention of investors with its promising therapeutic innovations and substantial growth potential. Despite current..

Crinetics Pharmaceuticals, Inc. (CRNX) Investor Outlook: A Potential 123.86% Upside in the Biotechnology Sector

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is capturing the attention of investors with its promising pipeline in the biotechnology sector, particularly in the rare endocrine diseases market. With a staggering potential..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a 151.88% Potential Upside in the Biotech Arena

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands as a compelling prospect for investors seeking to delve into the innovative realm of biotechnology. The company’s strategic focus on developing therapeutic antibodies for..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating Challenges with a 7.79% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a significant player in the healthcare sector, operates within the medical care facilities industry. As an operator of senior living communities across the United..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds